EXPERT INTERVIEWCME

Systemic Lupus Erythematosus: Treat to Target and Beyond

Author(s)/Faculty: Daniel J. Wallace, MD, FACP, MACR; Richard A. Furie, MD; Vaneet K. Sandhu, MD, RhMSUS, FACR
Release Date: 3/31/2022Expiration Date: 3/30/2023
Credit Type: CMENumber of Credits: 1
Content Type: LectureProvider:
Systemic lupus erythematosus (SLE) is an autoimmune disease occurring in children and adults, disproportionately affecting women of childbearing age. Profound racial/ethnic and socioeconomic health disparities have been shown to adversely impact lupus outcomes for people of color. This disease can lead to widespread inflammation and tissue damage involving multiple organ systems, including the skin, joints, kidneys, and brain. Early diagnosis and treatment are critical to prevent irreversible organ damage. With the recent influx of new options for treating SLE and lupus nephritis, ongoing education is essential to keep clinicians apprised of the latest clinical data and treatment recommendations. In this interactive web-based activity, faculty will review the importance of early detection and patient assessment, as well as evidence-based management. Experts will offer key guidance on strategies for early diagnosis, treatment, and addressing health disparities.